Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 585989, 11 pages
http://dx.doi.org/10.1155/2010/585989
Review Article

Systemic Inflammation in Chronic Obstructive Pulmonary Disease: May Adipose Tissue Play a Role? Review of the Literature and Future Perspectives

Department of Respiratory Medicine and Tuberculosis, Faculty of Medicine, P. J. Safarik University, L. Pasteur Teaching Hospital, Kosice 041 90, Slovakia

Received 6 November 2009; Revised 9 January 2010; Accepted 9 February 2010

Academic Editor: Giamila Fantuzzi

Copyright © 2010 Ruzena Tkacova. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Pauwels, A. S. Buist, P. M. A. Calverley, C. R. Jenkins, and S. S. Hurd, “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 5, pp. 1256–1276, 2001. View at Google Scholar · View at Scopus
  2. K. F. Rabe, S. Hurd, A. Anzueto et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 6, pp. 532–555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. J. Barnes and B. R. Celli, “Systemic manifestations and comorbidities of COPD,” European Respiratory Journal, vol. 33, no. 5, pp. 1165–1185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. F. M. Wouters, “Local and systemic inflammation in chronic obstructive pulmonary disease,” Proceedings of the American Thoracic Society, vol. 2, no. 1, pp. 26–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Fabbri and K. F. Rabe, “Multiple chronic diseases,” in Proceedings of a European Respiratory Society Research Seminar, Rome, Italy, February 2007.
  6. L. P. McGarvey, M. John, J. A. Anderson, M. Zvarich, and R. A. Wise, “Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee,” Thorax, vol. 62, no. 5, pp. 411–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Bruunsgaard and B. K. Pedersen, “Age-related inflammatory cytokines and disease,” Immunology and Allergy Clinics of North America, vol. 23, no. 1, pp. 15–39, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. D. Sin and S. F. Paul Man, “Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease,” Circulation, vol. 107, no. 11, pp. 1514–1519, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. L. M. G. Steuten, E. C. Creutzberg, H. J. M. Vrijhoef, and E. F. Wouters, “COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care,” Primary Care Respiratory Journal, vol. 15, no. 2, pp. 84–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. F. M. E. Franssen, D. E. O'Donnell, G. H. Goossens, E. E. Blaak, and A. M. W. J. Schols, “Obesity and the lung: 5. Obesity and COPD,” Thorax, vol. 63, no. 12, pp. 1110–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. M. Fabbri and K. F. Rabe, “From COPD to chronic systemic inflammatory syndrome?” The Lancet, vol. 370, no. 9589, pp. 797–799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Sevenoaks and R. A. Stockley, “Chronic obstructive pulmonary disease, inflammation and co-morbidity: a common inflammatory phenotype?” Respiratory Research, vol. 7, article 70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. M. Mannino, G. Watt, D. Hole et al., “The natural history of chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 27, no. 3, pp. 627–643, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Dentener, E. C. Creutzberg, A. M. Schols et al., “Systematic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations,” Thorax, vol. 56, pp. 721–726, 2001. View at Google Scholar
  15. D. M. Mannino, E. S. Ford, and S. C. Redd, “Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination,” American Journal of Medicine, vol. 114, no. 9, pp. 758–762, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. W. J. Schols, J. Slangen, L. Volovics, and E. F. M. Wouters, “Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 6, pp. 1791–1797, 1998. View at Google Scholar · View at Scopus
  17. C. Landbo, E. Prescott, P. Lange, J. Vestbo, and T. P. Almdal, “Prognostic value of nutritional status in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 1856–1861, 1999. View at Google Scholar · View at Scopus
  18. E. Prescott, T. Almdal, K. L. Mikkelsen, C. L. Tofteng, J. Vestbo, and P. Lange, “Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study,” European Respiratory Journal, vol. 20, no. 3, pp. 539–544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Koehler, W. Doehner, S. Hoernig, C. Witt, S. D. Anker, and M. John, “Anorexia in chronic obstructive pulmonary disease: association to cachexia and hormonal derangement,” International Journal of Cardiology, vol. 119, no. 1, pp. 83–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. W. Petersen, M. Penkowa, M. Iversen et al., “Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease,” Lung, vol. 185, no. 3, pp. 161–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. O. B. Margretardottir, S. J. Thorleifsson, G. Gudmundsson et al., “Hypertension, systemic inflammation and body weight in relation to lung function impairment: an epidemiological study,” Journal of Chronic Obstructive Pulmonary Disease, vol. 6, no. 4, pp. 250–255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. F. Connors Jr., N. V. Dawson, C. Thomas et al., “Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to understand prognoses and preferences for outcomes and risks of treatments),” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 4, pp. 959–967, 1996. View at Google Scholar · View at Scopus
  23. U. Kolsum, K. Roy, C. Starkey et al., “The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year,” Journal of Chronic Obstructive Pulmonary Disease, vol. 4, no. 1, pp. 149–156, 2009. View at Google Scholar · View at Scopus
  24. L. Watson, J. M. Vonk, C. G. Löfdahl et al., “Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study,” Respiratory Medicine, vol. 100, no. 4, pp. 746–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Kessler, M. Faller, G. Fourgaut, B. Mennecier, and E. Weitzenblum, “Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 1, pp. 158–164, 1999. View at Google Scholar · View at Scopus
  26. M. Vitacca, E. Clini, R. Porta, K. Foglio, and N. Ambrosino, “Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation,” European Respiratory Journal, vol. 9, no. 7, pp. 1487–1493, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Justo, S. Lachmi, N. Saar et al., “C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia,” European Journal of Internal Medicine, vol. 20, no. 5, pp. 518–521, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. de Torres, E. Cordoba-Lanus, C. Lopez-Aguillar et al., “C-reactive protein levels and clinically important predictive outcomes in stable COPD patients,” European Respiratory Journal, vol. 27, no. 5, pp. 902–907, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. F. P. Man, J. E. Connett, N. R. Anthonisen, R. A. Wise, D. P. Tashkin, and D. D. Sin, “C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease,” Thorax, vol. 61, no. 10, pp. 849–853, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. H. Vernooy, M. Kücükaycan, J. A. Jacobs et al., “Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 9, pp. 1218–1224, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Zeng, Y. Wen, L.-Y. Liu, H. Wang, K.-P. Guan, and X. Huang, “Role of TNF-alpha, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease,” Respiration, vol. 78, no. 4, pp. 399–403, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. K. F. Chung and I. M. Adcock, “Multifaceted mechanisms in COPD: inflammation, imunity, and tissue repair and destruction,” European Respiratory Journal, vol. 31, pp. 1334–1356, 2008. View at Google Scholar
  33. S. F. Van Eeden and D. D. Sin, “Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease,” Respiration, vol. 75, no. 2, pp. 224–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Kim, T. J. Rogers, and G. J. Criner, “New concepts in the pathobiology of chronic obstructive pulmonary disease,” Proceedings of the American Thoracic Society, vol. 5, no. 4, pp. 478–485, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S. M. Kennedy, R. K. Elwood, and B. J. R. Wiggs, “Increased airway mucosal permeability of smokers. Relationship to airway reactivity,” American Review of Respiratory Disease, vol. 129, no. 1, pp. 143–148, 1984. View at Google Scholar · View at Scopus
  36. P. Wollmer and E. Evander, “Biphasic pulmonary clearance of 99mTc-DTPA in smokers,” Clinical Physiology, vol. 14, no. 5, pp. 547–559, 1994. View at Google Scholar · View at Scopus
  37. D. S. Olivera, S. E. Boggs, C. Beenhouwer, J. Aden, and C. Knall, “Cellular mechanisms of mainstream cigarette smoke-induced lung epithelial tight junction permeability changes in vitro,” Inhalation Toxicology, vol. 19, no. 1, pp. 13–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Schmekel, L. Borgstrom, and P. Wollmer, “Difference in pulmonary absorption of inhaled terbutaline in healthy smokers and non-smokers,” Thorax, vol. 46, no. 4, pp. 225–228, 1991. View at Google Scholar · View at Scopus
  39. M. Fujita, J. M. Shannon, H. Ouchi, D. R. Voelker, Y. Nakanishi, and R. J. Mason, “Serum surfactant protein D is increased in acute and chronic inflammation in mice,” Cytokine, vol. 31, no. 1, pp. 25–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Tamagawa, K. Suda, Y. Wei et al., “Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation,” Innate Immunity, vol. 15, no. 4, pp. 251–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S.-H. Chou, Y.-W. Chen, H.-Y. Chuang, E.-L. Kao, and M.-F. Huang, “Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease,” Journal of Clinical Pharmacy and Therapeutics, vol. 31, no. 4, pp. 363–368, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. F. P. Man, Z. Xuekui, R. Vessey et al., “The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study,” Therapeutic Advances in Respiratory Disease, vol. 3, no. 2, pp. 73–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. S. A. Antoniu, “Inhaled corticosteroids in COPD: systemic effects of a local therapy?” Expert Opinion on Pharmacotherapy, vol. 9, pp. 3271–3273, 2008. View at Google Scholar
  44. L. Fontana, J. C. Eagon, M. E. Trujillo, P. E. Scherer, and S. Klein, “Visceral fat adipokine secretion is associated with systemic inflammation in obese humans,” Diabetes, vol. 56, no. 4, pp. 1010–1013, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Poulain, M. Doucet, V. Drapeau et al., “Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease,” Chronic Respiratory Disease, vol. 5, no. 1, pp. 35–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Marquis, F. Maltais, V. Duguay et al., “The metabolic syndrome in patients with chronic obstructive pulmonary disease,” Journal of Cardiopulmonary Rehabilitation, vol. 25, no. 4, pp. 226–232, 2005. View at Google Scholar · View at Scopus
  47. J. Vestbo, E. Prescott, T. Almdal et al., “Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 1, pp. 79–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. M. P. K. J. Engelen, A. M. W. J. Schols, R. J. S. Lamers, and E. F. M. Wouters, “Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease,” Clinical Nutrition, vol. 18, no. 5, pp. 275–280, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Sergi, A. Coin, S. Marin et al., “Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease,” Respiratory Medicine, vol. 100, no. 11, pp. 1918–1924, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Liu, Y. Ji, J. Chen, S. Li, and F. Luo, “Circulating visfatin in chronic obstructive pulmonary disease,” Nutrition, vol. 25, no. 4, pp. 373–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Poulain, M. Doucet, G. C. Major et al., “The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies,” Canadian Medical Association Journal, vol. 174, no. 9, pp. 1293–1299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Leone, D. Courbon, F. Thomas et al., “Lung function impairment and metabolic syndrome the critical role of abdominal obesity,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 6, pp. 509–516, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. K.-B. H. Lam, R. E. Jordan, C. Q. Jiang et al., “Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study,” European Respiratory Journal, vol. 35, no. 2, pp. 317–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Guerra, D. L. Sherrill, A. Bobadilla, F. D. Martinez, and R. A. Barbee, “The relation of body mass index to asthma, chronic bronchitis, and emphysema,” Chest, vol. 122, no. 4, pp. 1256–1263, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. D. F. Schokker, T. L. S. Visscher, A. C. J. Nooyens, M. A. Van Baak, and J. C. Seidell, “Prevalence of overweight and obesity in the Netherlands,” Obesity Reviews, vol. 8, no. 2, pp. 101–108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. N. H. T. ten Hacken, “Physical inactivity and obesity: relation to asthma and chronic obstructive pulmonary disease?” Proceedings of the American Thoracic Society, vol. 6, no. 8, pp. 663–667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Watz, B. Waschki, A. Kirsten et al., “The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity,” Chest, vol. 136, no. 4, pp. 1039–1046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Garcia-Aymerich, P. Lange, M. Benet, P. Schnohr, and J. M. Antó, “Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 5, pp. 458–463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. C. E. Bolton, M. Evans, A. A. Ionescu et al., “Insulin resistance and inflammation: a further systemic complication of COPD,” Journal of Chronic Obstructive Pulmonary Disease, vol. 4, no. 2, pp. 121–126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Koehler, W. Doehner, S. Hoernig, C. Witt, S. D. Anker, and M. John, “Anorexia in chronic obstructive pulmonary disease: association to cachexia and hormonal derangement,” International Journal of Cardiology, vol. 119, no. 1, pp. 83–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Landbo, E. Prescott, P. Lange, J. Vestbo, and T. P. Almdal, “Prognostic value of nutritional status in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 1856–1861, 1999. View at Google Scholar · View at Scopus
  62. J. Vestbo, E. Prescott, T. Almdal et al., “Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 1, pp. 79–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. M. J. Tisdale, “Mechanisms of cancer cachexia,” Physiological Reviews, vol. 89, no. 2, pp. 381–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Miján-de-la-Torre, “Recent insights on chronic heart failure, cachexia and nutrition,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 12, no. 3, pp. 251–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Fleet, F. Osman, R. Komaragiri, A. Fritz, and D. S. C. Raj, “Protein catabolism in advanced renal disease: role of cytokines,” Clinical Nephrology, vol. 70, no. 2, pp. 91–100, 2008. View at Google Scholar · View at Scopus
  66. M. Gelato, M. McNurlan, and E. Freedland, “Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment,” Clinical Therapeutics, vol. 29, no. 11, pp. 2269–2288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Trayhurn and J. H. Beattie, “Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ,” Proceedings of the Nutrition Society, vol. 60, pp. 329–339, 2001. View at Google Scholar · View at Scopus
  68. E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Trayhurn and I. S. Wood, “Adipokines: inflammation and the pleiotropic role of white adipose tissue,” British Journal of Nutrition, vol. 92, no. 3, pp. 347–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. V. Mohamed-Ali, S. Goodrick, A. Rawesh et al., “Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4196–4200, 1997. View at Google Scholar · View at Scopus
  71. G. S. Hotamisligil, P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman, “Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2409–2415, 1995. View at Google Scholar · View at Scopus
  72. J. P. Warne, “Tumour necrosis factor alpha: a key regulator of adipose tissue mass,” Journal of Endocrinology, vol. 177, no. 3, pp. 351–355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Ruan, N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish, “Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory,” Diabetes, vol. 51, no. 5, pp. 1319–1336, 2002. View at Google Scholar · View at Scopus
  74. V. Mohamed-Ali, L. Flower, J. Sethi et al., “Beta-adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies,” Journal of Clinical Endocrinology and Metabolism, vol. 86, pp. 5864–5869, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. P. A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan, “Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance,” American Journal of Physiology, vol. 280, no. 5, pp. E745–E751, 2001. View at Google Scholar · View at Scopus
  76. A. S. Greenberg, R. P. Nordan, J. McIntosh, J. C. Calvo, R. O. Scow, and D. Jablons, “Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia,” Cancer Research, vol. 52, no. 15, pp. 4113–4116, 1992. View at Google Scholar · View at Scopus
  77. G. Strassmann, M. Fong, J. S. Kenney, and C. O. Jacob, “Evidence for the involvement of interleukin 6 in experimental cancer cachexia,” Journal of Clinical Investigation, vol. 89, no. 5, pp. 1681–1684, 1992. View at Google Scholar · View at Scopus
  78. J. M. Bruun, S. B. Pedersen, K. Kristensen, and B. Richelsen, “Opposite regulation of interleukin-8 and tumor necrosis factor-alpha by weight loss,” Obesity Research, vol. 10, no. 6, pp. 499–506, 2002. View at Google Scholar · View at Scopus
  79. M. S. Zumbach, M. W. J. Boehme, P. Wahl, W. Stremmel, R. Ziegler, and P. P. Nawroth, “Tumor necrosis factor increases serum leptin levels in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4080–4082, 1997. View at Google Scholar · View at Scopus
  80. S. Loffreda, S. Q. Yang, H. Z. Lin et al., “Leptin regulates proinflammatory immune responses,” FASEB Journal, vol. 12, no. 1, pp. 57–65, 1998. View at Google Scholar · View at Scopus
  81. M. Haluzik, M. Matoulek, S Svacina et al., “The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females,” Endocrine Research, vol. 27, no. 1-2, pp. 251–260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. D. D. Sin and S. F. P. Man, “Impaired lung function and serum leptin in men and women with normal body weight: a population based study,” Thorax, vol. 58, no. 8, pp. 695–698, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. E. C. Creutzberg, A. M. Schols, C. A. Weling-Scheepers, W. A. Buurman, and E. F. M. Wouters, “Characterization of nonresponse to high caloric oral nutritional therapy m depleted patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 3, pp. 745–752, 2000. View at Google Scholar · View at Scopus
  84. T. Yamauchi, J. Kamon, H. Waki et al., “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,” Nature Medicine, vol. 7, no. 8, pp. 941–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. J. M. Bruun, A. S. Lihn, C. Verdich et al., “Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans,” American Journal of Physiology, vol. 285, no. 3, pp. E527–E533, 2003. View at Google Scholar · View at Scopus
  86. G. Krommidas, K. Kostikas, G. Papatheodorou et al., “Plasma lepin and adiponectin in COPD exacerbations: associations with inflammatorz biomarkers,” Respiratory Medicine, vol. 104, no. 1, pp. 40–41, 2010. View at Google Scholar
  87. T. Skurk, C. Alberti-Huber, C. Herder, and H. Hauner, “Relationship between adipocyte size and adipokine expression and secretion,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 3, pp. 1023–1033, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. J.-P. Bastard, C. Jardel, E. Bruckert et al., “Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 3338–3342, 2000. View at Google Scholar · View at Scopus
  89. M. Maachi, L. Pieroni, E. Bruckert et al., “Systemic low-grade inflammation is related to both circulating and adipose tissue TNFa, leptin and IL-6 levels in obese women,” International Journal of Obesity, vol. 28, no. 8, pp. 993–997, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. M.-C. Alessi, D. Bastelica, P. Morange et al., “Plasminogen activator inhibitor 1, transforming growth factor-b1, and BMI are closely associated in human adipose tissue during morbid obesity,” Diabetes, vol. 49, no. 8, pp. 1374–1380, 2000. View at Google Scholar · View at Scopus
  91. L. K. M. Summers, J. S. Samra, S. M. Humphreys, R. J. Morris, and K. N. Frayn, “Subcutaneous abdominal adipose tissue blood now: variation within and between subjects and relationship to obesity,” Clinical Science, vol. 91, no. 6, pp. 679–683, 1996. View at Google Scholar · View at Scopus
  92. B. Chen, K. S. L. Lam, Y. Wang et al., “Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes,” Biochemical and Biophysical Research Communications, vol. 341, no. 2, pp. 549–556, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. N. Hosogai, A. Fukuhara, K. Oshima et al., “Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation,” Diabetes, vol. 56, no. 4, pp. 901–911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. R. H. Wenger, “Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression,” FASEB Journal, vol. 16, no. 10, pp. 1151–1162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. I. F. Charo and M. B. Taubman, “Chemokines in the pathogenesis of vascular disease,” Circulation Research, vol. 95, no. 9, pp. 858–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. S. E. Shoelson, J. Lee, and M. Yuan, “Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance,” International Journal of Obesity, vol. 27, supplement 3, pp. S49–S52, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. G. L. Semenza, “HIF-1 and mechanisms of hypoxia sensing,” Current Opinion in Cell Biology, vol. 13, no. 2, pp. 167–171, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. G. L. Semenza, “Targeting HIF-1 for cancer therapy,” Nature Reviews Cancer, vol. 3, no. 10, pp. 721–732, 2003. View at Google Scholar · View at Scopus
  99. S. Rocha, “Gene regulation under low oxygen: holding your breath for transcription,” Trends in Biochemical Sciences, vol. 32, no. 8, pp. 389–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. P. Trayhurn, B. Wang, and I. S. Wood, “Hypoxia and the endocrine and signalling role of white adipose tissue,” Archives of Physiology and Biochemistry, vol. 114, no. 4, pp. 267–276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. N. Takabatake, H. Nakamura, S. Abe et al., “The relationship between chronic hypoxemia and activation of the tumor necrosis factor-aplha system in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 4, pp. 1179–1184, 2000. View at Google Scholar · View at Scopus
  102. G. S. Supinski and L. A. Callahan, “Free radical-mediated skeletal muscle dysfunction in inflammatory conditions,” Journal of Applied Physiology, vol. 102, no. 5, pp. 2056–2063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Tkacova, Z. Kluchova, P. Joppa, D. Petrasova, and A. Molcanyiova, “Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD,” Respiratory Medicine, vol. 101, no. 8, pp. 1670–1676, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. P. Lévy, M. R. Bonsignore, and J. Eckel, “Sleep, sleep-disordered breathing and metabolic consequences,” European Respiratory Journal, vol. 34, no. 1, pp. 243–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Barcelo, F. Barbe, E. Llompart et al., “Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea,” American Journal of Medicine, vol. 117, no. 2, pp. 118–121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Ryan, C. T. Taylor, and W. T. McNicholas, “Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 7, pp. 824–830, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. Z. Dorkova, D. Petrasova, A. Molcanyiova, M. Popovnakova, and R. Tkacova, “Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome,” Chest, vol. 134, no. 4, pp. 686–692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. J. Li, D. N. Grigoryev, S. Q. Ye et al., “Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice,” Journal of Applied Physiology, vol. 99, no. 5, pp. 1643–1648, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. N. Iiyori, L. C. Alonso, J. Li et al., “Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 8, pp. 851–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Li, V. Savransky, A. Nanayakkara, P. L. Smith, C. P. O'Donnell, and V. Y. Polotsky, “Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia,” Journal of Applied Physiology, vol. 102, no. 2, pp. 557–563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. T. Yokoe, L. C. Alonso, L. C. Romano et al., “Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic ß-cell replication in mice,” Journal of Physiology, vol. 586, no. 3, pp. 899–911, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Bruno, P. Chanez, G. Chiappara et al., “Does leptin play a cytokine-like role within the airways of COPD patients?” European Respiratory Journal, vol. 26, no. 3, pp. 398–405, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Miller, J. Y. Cho, A. Pham, J. Ramsdell, and D. H. Broide, “Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease,” Journal of Immunology, vol. 182, no. 1, pp. 684–691, 2009. View at Google Scholar · View at Scopus
  114. J. H. J. Vernooy, N. E. A. Drummen, R. J. van Suylen et al., “Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers,” Thorax, vol. 64, no. 1, pp. 26–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. N. N. Hansel, L. Gao, N. M. Rafaels et al., “Leptin receptor polymorphisms and lung function decline in COPD,” European Respiratory Journal, vol. 34, no. 1, pp. 103–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. S. A. Shore, R. D. Terry, L. Flynt, A. Xu, and C. Hug, “Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice,” Journal of Allergy and Clinical Immunology, vol. 118, no. 2, pp. 389–395, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. G. L. Sorensen, J. V. B. Hjelmborg, R. Leth-Larsen et al., “Surfactant protein D of the innate immune defence is inversely associated with human obesity and SP-D deficiency infers increased body weight in mice,” Scandinavian Journal of Immunology, vol. 64, no. 6, pp. 633–638, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. G. L. Sørensen, J. V.B. Hjelmborg, K. O. Kyvik et al., “Genetic and environmental influences of surfactant protein D serum levels,” American Journal of Physiology, vol. 290, no. 5, pp. L1010–L1017, 2006. View at Publisher · View at Google Scholar · View at Scopus